{"filings":[{"id":91539,"accession_number":"0001628280-26-032217","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare Q1 2026 revenue down 18% YoY, net loss widens to $4.3M","event_type":"earnings","confidence":"high","bullets":["Revenue $241.1M, down 18% YoY; gross profit margin 19.7%, down 30 bps.","Net loss attributable to common stockholders $4.3M vs $0.5M loss in Q1 2025.","Diluted EPS loss $0.14; adjusted EPS loss $0.03.","Adjusted EBITDA $3.9M, down 55% YoY; adjusted EBITDA margin 1.6%.","Cash flow from operations $4.8M, down 16% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":241057000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91538,"accession_number":"0000950103-26-006921","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["1.01","7.01","8.01","9.01"],"status":"ready","headline":"Cross Country Healthcare to be acquired by Knox Lane for $13.25/share in $437M all-cash deal","event_type":"m_and_a","confidence":"high","bullets":["Deal valued at ~$437M, with stockholders receiving $13.25 per share in cash.","31% premium to May 6 closing price and 45% premium to 90-day VWAP.","Expected to close Q3 2026, subject to stockholder approval and HSR clearance.","Company cancels Q1 2026 earnings call (May 7) and 2026 Annual Meeting (May 11).","Equity financing from Knox Lane secured; termination fee of ~$14.2M applies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91537,"accession_number":"0001628280-26-025765","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-04-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare schedules Q1 2026 earnings call for May 7","event_type":"other_material","confidence":"high","bullets":["Earnings call on May 7, 2026 at 5:00 PM ET after market close.","Results will be released after market close on the same day.","Dial-in: US 800-369-2163 or Intl 773-756-4715, passcode: Cross Country.","Webcast accessible at ir.crosscountry.com; replay through May 21."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101693,"accession_number":"0000929638-26-001241","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-03-30T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Cross Country Healthcare appoints Amiee Hawkins as COO effective March 28","event_type":"leadership","confidence":"high","bullets":["Hawkins, previously Chief Solutions & Operations Officer, promoted to COO.","She joined the company in 2014 and held multiple VP and SVP roles.","No change to her compensation or new agreement was made in connection with the appointment.","No family relationships with directors or executive officers; no arrangement with any person.","Board approved the appointment on March 25, 2026, effective March 28, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101692,"accession_number":"0000929638-26-001038","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-03-17T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cross Country Healthcare CIO Phil Noe departs; receives $205,975 severance, consulting role","event_type":"leadership","confidence":"high","bullets":["Phil Noe ceased as Chief Information Officer effective March 10, 2026.","Noe will receive $205,975 severance (six months salary) under Separation Agreement.","Noe entered into Consulting Agreement from March 11 to May 31, 2026 at $198.04/hour.","Noe will provide consulting on technology, telephones, and related infrastructure.","No replacement for CIO role announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101691,"accession_number":"0000929638-26-000955","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-03-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cross Country Healthcare appoints Marvin Veizaga as CAO; James Redd and Phil Noe depart","event_type":"leadership","confidence":"high","bullets":["James V. Redd III ceases as SVP & Chief Accounting Officer effective March 10, 2026; no dispute with company.","Phil Noe ceases as Chief Information Officer effective March 10, 2026; departure not due to disagreement.","Marvin Veizaga, previously Group VP Corporate Controller, appointed SVP & CAO, reporting to CFO.","Veizaga receives base salary increase to $340,000; STI and LTI targets each at 50% of base salary.","No family relationships or material interest in transactions for new CAO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101690,"accession_number":"0001628280-26-014650","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare Q4 2025 revenue down 24% YoY; net loss of $82.9M","event_type":"earnings","confidence":"high","bullets":["Revenue $236.8M in Q4 2025, down 24% YoY; full-year revenue $1.054B, down 22%.","Net loss attributable to common $82.9M in Q4 versus $3.8M loss a year ago; diluted EPS $(2.56).","Adjusted EBITDA $4.1M in Q4, margin 1.7% (down 130bps YoY); full-year adjusted EBITDA $26.8M.","Cash from operations $18.2M in Q4; full year $48.3M, down 60% YoY.","Adjusted EPS was $(0.06) in Q4 vs $0.04 in prior-year quarter; full-year adjusted EPS $0.02."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101689,"accession_number":"0001628280-26-010662","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-02-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare to attend two investor conferences in March 2026","event_type":"other","confidence":"high","bullets":["Truist Securities Virtual Human Capital Conference March 12-13, one-on-one March 12.","Oppenheimer Healthcare MedTech & Services Conference March 16-19, one-on-one March 17.","CFO William J. Burns and VP IR Josh Vogel to attend both conferences.","No formal presentation will be made at either event."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101688,"accession_number":"0001628280-26-007704","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-02-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare schedules Q4/FY 2025 earnings call for March 4, 2026","event_type":"other","confidence":"high","bullets":["Earnings call on Wednesday, March 4, 2026 at 5:00 PM ET.","Press release with financial results to be issued after market close on March 4.","Dial-in: 800-369-2163 (U.S.) or 773-756-4715 (non-U.S.); passcode: Cross Country.","Webcast available at ir.crosscountry.com; replay through March 18."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101687,"accession_number":"0001628280-26-004147","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2026-01-29T23:59:59+00:00","items":["5.08","8.01"],"status":"ready","headline":"Cross Country Healthcare sets 2026 annual meeting for May 11, updates proposal deadlines","event_type":"other","confidence":"high","bullets":["2026 annual meeting will be held virtually on May 11, 2026.","Stockholder proposals under Rule 14a-8 must be received by March 11, 2026.","Advance notice for nominations or other business due by February 10, 2026.","Universal proxy rule notices required by March 12, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101686,"accession_number":"0001628280-26-000149","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K/A","filed_at":"2026-01-02T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Cross Country Healthcare discloses CEO Kevin Clark's employment terms: $950K salary, bonus, equity","event_type":"leadership","confidence":"high","bullets":["Base salary $950K; 2026 target bonus 100% of base (max 180%), rising to 125% target from 2027.","Long-term equity: 275% of base for 2025, 300% for 2026, 325% for 2027 and 2028.","Severance on termination without cause/good reason: 24 months base salary plus 2x average bonus, plus COBRA.","Initial 3-year term through Dec 14, 2028, with automatic one-year renewals unless 90-day non-renewal notice.","Non-compete and non-solicitation covenants apply for 2 years post-employment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118018,"accession_number":"0001628280-25-056873","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-12-15T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Cross Country CEO Martins departs; co-founder Clark returns as CEO after Aya deal termination","event_type":"leadership","confidence":"high","bullets":["CEO John Martins separated effective Dec 14, 2025; receives severance of 2-year base salary ($875K) plus average bonus.","Chairman and co-founder Kevin Clark appointed President and CEO; will continue as Chairman.","Transition follows termination of transaction with Aya Healthcare; Board believes it's the right time for change.","Clark previously led Cross Country as CEO from 2019 to 2022, a period of rapid growth and strong financial results.","Company plans to sharpen focus, reduce costs, optimize capital allocation for sustainable profitable growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118017,"accession_number":"0001628280-25-056541","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-12-11T23:59:59+00:00","items":["5.07","9.01"],"status":"ready","headline":"Cross Country Healthcare elects 7 directors, ratifies Deloitte, approves say-on-pay at annual meeting","event_type":"other","confidence":"high","bullets":["All 7 director nominees elected with strong support; Gale Fitzgerald received the most against votes at 2,651,031.","Ratification of Deloitte & Touche as independent auditor for FY2025 approved with 25,759,187 for, 48,300 against.","Advisory vote on executive compensation approved with 21,724,841 for, 279,383 against.","Broker non-votes existed 3,660,974 on director election and say-on-pay items."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118016,"accession_number":"0000950103-25-015716","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-12-04T23:59:59+00:00","items":["1.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare merger with Aya Healthcare terminated; to receive $20M fee; starts buybacks","event_type":"other_material","confidence":"high","bullets":["Merger agreement with Aya Healthcare terminated effective Dec 4, 2025 after failing to close by Dec 3, 2025 end date.","Aya to pay Cross Country a $20 million termination fee within two business days.","Termination due to FTC review not completed; HSR waiting period extended to Dec 30, 2025 because of 43-day government shutdown.","Company to immediately commence share repurchases under existing $40 million authorization.","Company reports no debt and strong cash position; refocuses on standalone strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118015,"accession_number":"0001628280-25-051671","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare Q3 revenue $250M, down 21% YoY; net loss $4.8M","event_type":"earnings","confidence":"high","bullets":["Revenue $250.1M, down 21% YoY and 9% sequentially; gross margin 20.4% flat.","Net loss $4.8M vs $1.2M in Q3 2024; diluted EPS ($0.15) vs ($0.23) prior year.","Adjusted EBITDA $6.5M, down 37% YoY; adjusted EPS $0.03 vs ($0.09) a year ago.","Cash from operations $20.1M, up 169% YoY and 377% sequentially."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":817532000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134474,"accession_number":"0001628280-25-043262","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-09-30T23:59:59+00:00","items":["5.08","8.01"],"status":"ready","headline":"Cross Country Healthcare sets annual meeting for Dec 9, conditional on Aya merger not closing first","event_type":"other_material","confidence":"high","bullets":["Annual Meeting scheduled for virtual-only on December 9, 2025; proxy statement available on or before Oct 30.","Meeting will only occur if Aya merger is not completed before Dec 9; if closed, company becomes Aya subsidiary and meeting cancelled.","Stockholder proposals for Rule 14a-8 inclusion must be received by Oct 10, 2025.","Director nominations and universal proxy notices also due Oct 10, 2025.","Company still expects Aya merger to close in Q4 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134473,"accession_number":"0000950103-25-011190","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-09-03T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Cross Country Healthcare extends merger deadline to Dec 3, 2025; FTC compliance certified","event_type":"m_and_a","confidence":"high","bullets":["Merger end date automatically extended from Sept 3, 2025 to Dec 3, 2025 per the Merger Agreement.","Cross Country and Aya have each certified substantial compliance with FTC's Second Request as of Aug 29, 2025.","Merger expected to close in Q4 2025, subject to regulatory approvals and customary conditions.","Terms of the Merger Agreement remain unchanged; other than the End Date extension."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134472,"accession_number":"0001628280-25-038369","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare Q2 revenue down 19% YoY, net loss of $6.7M, negative adjusted EPS","event_type":"earnings","confidence":"high","bullets":["Revenue $274.1M, down 19% YoY; gross margin 20.4%, down 40 bps.","Net loss attributable to common stockholders $6.7M ($0.20 diluted EPS loss); vs Q2 2024 EPS of $0.27 income.","Adjusted EBITDA $7.6M (2.8% margin), down 46% YoY.","Adjusted EPS loss of $0.01, improved from $0.11 loss in Q2 2024.","Cash from operations $4.2M, down 95% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":567480000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151317,"accession_number":"0001628280-25-023205","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Q1 revenue down 23% YoY to $293.4M; adjusted EPS $0.06","event_type":"earnings","confidence":"high","bullets":["Revenue $293.4M, down 23% YoY; net loss $490K ($0.02 loss per share).","Adjusted EBITDA $8.6M (2.9% margin); adjusted EPS $0.06, improving from $(0.13) YoY.","Gross profit margin 20.0%, down 40bps YoY.","Operating cash flow $5.7M, down 5% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":293408000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170202,"accession_number":"0001628280-25-010495","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-03-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cross Country Healthcare reports Q4 2024 revenue down 25% YoY, net loss of $3.8M","event_type":"earnings","confidence":"high","bullets":["Q4 2024 revenue $309.9M, down 25% YoY and 2% sequentially.","Q4 net loss $3.8M ($0.12 diluted EPS); full year net loss $14.6M.","Adjusted EBITDA $9.3M (-55% YoY); adjusted EPS $0.04.","Full year 2024 revenue $1.34B, down 33% from 2023.","Operating cash flow Q4 $24.2M, up 101% YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170201,"accession_number":"0000950103-25-002748","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-02-28T23:59:59+00:00","items":["5.07","8.01","9.01"],"status":"ready","headline":"Stockholders approve Aya Healthcare acquisition; merger expected H2 2025","event_type":"m_and_a","confidence":"high","bullets":["Over 78% of shares voted; 25.66M votes for Merger Agreement, 11K against.","Advisory merger-related compensation proposal also approved with 24.3M votes for.","Merger expected to close in second half of 2025, subject to customary conditions.","Upon close, Cross Country becomes private; CCRN common stock to be delisted from NASDAQ."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170200,"accession_number":"0000950103-25-002303","cik":1141103,"company_name":"CROSS COUNTRY HEALTHCARE INC","ticker":"CCRN","form_type":"8-K","filed_at":"2025-02-21T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Cross Country Healthcare receives FTC Second Request for Aya merger; close expected H2 2025","event_type":"regulatory","confidence":"high","bullets":["FTC issued Second Request under HSR Act, extending waiting period until 30 days after substantial compliance by both parties.","Merger close now expected in second half of 2025, delayed from previous timeline.","Company and Aya are working cooperatively with FTC; continue to respond to request.","Merger still requires stockholder approval and other customary closing conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}